Literature DB >> 18519411

Update on T-cell lymphoma.

J M Vose1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519411     DOI: 10.1093/annonc/mdn203

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  The curious origins of angioimmunoblastic T-cell lymphoma.

Authors:  José R Cortés; Teresa Palomero
Journal:  Curr Opin Hematol       Date:  2016-07       Impact factor: 3.284

2.  Primary myelofibrosis with concurrent precursor T-cell lymphoblastic lymphoma of the spleen in a 26-year-old patient.

Authors:  Matjaz Sever; Jeffrey L Jorgensen; Inga Gurevich; Mariana Pinheiro; Srdan Verstovsek
Journal:  Leuk Res       Date:  2009-05-30       Impact factor: 3.156

3.  131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma.

Authors:  Ajay K Gopal; John M Pagel; Jonathan R Fromm; Shani Wilbur; Oliver W Press
Journal:  Blood       Date:  2009-03-30       Impact factor: 22.113

4.  Genomic instability and rapid clinical course in adult T-cell lymphoma/leukemia patient.

Authors:  Adriana Zámecníkova; Soad Al Bahar; Samah E Elshinnawy
Journal:  Leuk Res       Date:  2010-03-07       Impact factor: 3.156

5.  Derivation and validation of a lipid-covered prognostic model for mature T-cell lymphomas.

Authors:  Tiange Lu; Lei Shi; Guanggang Shi; Yiqing Cai; Shunfeng Hu; Jiarui Liu; Shuai Ren; Xiangxiang Zhou; Xin Wang
Journal:  Cancer Cell Int       Date:  2021-07-05       Impact factor: 5.722

6.  Leptin and its receptor in glucose metabolism of T-cell lymphoma.

Authors:  Tian-Jie Han; Hong-Zhi Xu; Jun-Shan Li; Ling-Yun Geng; Xin-Yu Li; Xiang-Xiang Zhou; Xin Wang
Journal:  Oncol Lett       Date:  2018-08-23       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.